Last reviewed · How we verify

NCT04665908

PT-led Triage for Patients With Hip o Knee Osteoarthritis

Active, enrolled NA Last updated 11 May 2025
What this trial tests

NA trial testing Assessment by PT/Orth surgeon in Knee Osteoarthritis in 675 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
26 October 2020
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorSahlgrenska University Hospital
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment675
Start date26 October 2020
Primary completion31 December 2025
Estimated completion31 December 2025
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Sahlgrenska University Hospital

Who can join

Eligibility, any sex, with Knee Osteoarthritis or Hip Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to compare PT-led triage in secondary care setting for patients with hip or/and knee osteoarthritis (OA) with standard care (i.e. assessment of orthopedic surgeon). Comparison between cost-effectiveness, selection accuracy, patients perceived quality of care, quality of life and physical function will be made. A further aim is to explore patients expectations and experiences of PT-led triage in a secondary care setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Sahlgrenska University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04665908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing